(Reuters) – Moderna Inc’s COVID-19 vaccine showed modest reductions in neutralizing antibodies against emerging variants, including the Delta variant first
Modernas COVID-19 Vaccine Shows Promise Against Delta Variant in Lab Study

besthealthtale.com
Home » covid-19 vaccine »
(Reuters) – Moderna Inc’s COVID-19 vaccine showed modest reductions in neutralizing antibodies against emerging variants, including the Delta variant first
NEW YORK (Reuters) – Infectious disease experts are weighing the need for booster shots of the Pfizer/BioNTech or Moderna mRNA-based
MOSCOW (Reuters) – The Kremlin on Friday blamed a surge in COVID-19 cases on reluctance to have vaccinations and “nihilism”
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In Tennessee and North Carolina, demand
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Another study has suggested that rates
BERLIN (Reuters) – Germans desperate to be vaccinated against the coronavirus are becoming increasingly aggressive, doctors said on Wednesday, as
LONDON (Reuters) – Data from the rollout of AstraZeneca’s COVID-19 vaccine shows one dose of the shot is associated with
BRUSSELS (Reuters) – European countries distanced themselves on Friday from a proposal backed by U.S. President Joe Biden to waive
LONDON (Reuters) – Pascal Soriot, who is under intense fire from the European Union over the delivery of AstraZeneca’s COVID-19
ZURICH (Reuters) – Novartis is scaling up facilities to make COVID-19 vaccine doses for German drugmaker CureVac and could boost